Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, Top Penny, bz777, UndervaluedStocks, whento
Search This Board: 
Last Post: 8/16/2017 10:54:50 AM - Followers: 442 - Board type: Free - Posts Today: 18



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#51900  Sticky Note Last summarised ARYC_microarray_business_reports from May - July 2017 HighYieldStocks 07/29/17 03:01:07 PM
#49456  Sticky Note Attention all new investors in ARYC!! whento 07/12/17 10:40:46 PM
#47743  Sticky Note Ladies and Gentlemen, as incredulous as it may spotlight1 06/29/17 01:44:26 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#53490   6 trades in 90 minutes!!!! jrsh 08/16/17 10:54:50 AM
#53489   I think you get my point with the Delsurfer 08/16/17 10:46:37 AM
#53488   1. Why would anyone pay for a Alyssa 08/16/17 10:31:16 AM
#53487   Just hit the ask with a couple of millions!!!!lol jrsh 08/16/17 10:20:45 AM
#53486   Not intending to start a debate here. Delsurfer 08/16/17 10:03:35 AM
#53485   nice ask slap and Bid is creeping up.Lets whento 08/16/17 10:00:32 AM
#53484   We need NITE & CDEL to get off Toofast 08/16/17 09:59:43 AM
#53483   Everyone is holding their shares now. Weak hands UndervaluedStocks 08/16/17 09:52:42 AM
#53482   I have no doubt it'll be a dollar Toofast 08/16/17 09:41:01 AM
#53481   Well that's 75% less than a dollar, so DemGains 08/16/17 09:39:12 AM
#53480   Hows Everyone ARYC$$$ Meq 08/16/17 09:37:50 AM
#53479   The projected PPS is around .25¢ a share Toofast 08/16/17 09:35:03 AM
#53477   I don't care if they paid for it Alyssa 08/16/17 09:18:11 AM
#53476   That doesn't change the fact that this company's DemGains 08/16/17 09:05:03 AM
#53475   There is but the float is mostly locked up! Toofast 08/16/17 08:33:12 AM
#53474   Did I just read there are over billion DemGains 08/16/17 08:28:50 AM
#53473   ARYC is a stock to accumulate for generational Penny Traders Club 08/16/17 12:30:13 AM
#53472   For those who are new to the board: UndervaluedStocks 08/15/17 11:43:53 PM
#53471   Aryc oversold and will skyrocket soon: Ken1998 08/15/17 08:28:37 PM
#53470   Aryc is stock in investors sights: Ken1998 08/15/17 08:26:06 PM
#53469   Because the list is in alphabetical order perhaps:) Delsurfer 08/15/17 08:24:51 PM
#53468   Aryc will go up! Ken1998 08/15/17 08:22:17 PM
#53466   Great info, thanks. Believe me, I want ScorpGirl 08/15/17 06:22:08 PM
#53465   All it takes is a few phone calls UndervaluedStocks 08/15/17 05:54:04 PM
#53464   Maybe, but it took them almost 2 years Full Contact Yoga 08/15/17 05:42:12 PM
#53463   Do a search on microarray and Arrayit is UndervaluedStocks 08/15/17 05:36:07 PM
#53462 UndervaluedStocks 08/15/17 05:34:21 PM
#53461   I've talked to people in the medical development ScorpGirl 08/15/17 05:08:51 PM
#53460   omg.....the MMs about if the company files jrsh 08/15/17 04:54:41 PM
#53458   Talking heads want your shares! Penny Traders Club 08/15/17 04:46:45 PM
#53457   You know they paid for that to be Delsurfer 08/15/17 04:43:47 PM
#53456   Talking heads out to get ARYC Penny Traders Club 08/15/17 04:43:42 PM
#53455   IMO there's some obvious manipulation going on Penny Traders Club 08/15/17 04:43:08 PM
#53454   Nice strong day...this will explode whenever these MM HighYieldStocks 08/15/17 04:35:24 PM
#53453   Try talking to people instead of doing your UndervaluedStocks 08/15/17 04:33:33 PM
#53452   I checked with the TA and as of Penny Traders Club 08/15/17 04:32:01 PM
#53451   Show me the proof that they are. MikeCr 08/15/17 04:31:39 PM
#53450   The AVDX shares held by Arrayit are worth MikeCr 08/15/17 04:28:58 PM
#53449   That loan is being paid off substantially every UndervaluedStocks 08/15/17 04:27:26 PM
#53448   Ha ha there's no indication that they have MikeCr 08/15/17 04:25:53 PM
#53447   Holding long ! Will be worth the wait TravO 08/15/17 03:59:17 PM
#53446   L2 is very strong. Sellers yesterday are weeping. UndervaluedStocks 08/15/17 03:57:46 PM
#53445   Small minded flippers are controlling the ARYC board UndervaluedStocks 08/15/17 03:41:38 PM
#53444   Excerpt re ARYC: "Tracing its roots back Alyssa 08/15/17 03:28:07 PM
#53443   Grab those cheapies while you can Penny Traders Club 08/15/17 03:28:02 PM
#53442   How about jumping to a nickel? lambchops 08/15/17 03:20:17 PM
#53441   "Major Player" and "Huge Revenues" might be stretching Delsurfer 08/15/17 03:11:11 PM
#53440   Thank you for echoing my point...your post speaks thousands! spotlight1 08/15/17 03:04:25 PM
#53439   Have you STILL not heard? They are Alyssa 08/15/17 02:56:31 PM
#53438   You are kidding, right? But also there Alyssa 08/15/17 02:53:33 PM